Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Recommendation of “Moderate Buy” by Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $40.7727.

Several analysts recently commented on the stock. KeyCorp reduced their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Barclays reduced their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, August 7th. Raymond James Financial reiterated an “outperform” rating and issued a $26.00 price target (down previously from $40.00) on shares of Acadia Healthcare in a research report on Thursday, August 14th. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Finally, Stephens upgraded shares of Acadia Healthcare to a “hold” rating in a research report on Monday, June 2nd.

Hedge Funds Weigh In On Acadia Healthcare

A number of large investors have recently bought and sold shares of the company. Verdence Capital Advisors LLC raised its position in Acadia Healthcare by 3.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company’s stock worth $333,000 after buying an additional 465 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. PNC Financial Services Group Inc. raised its position in Acadia Healthcare by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after buying an additional 622 shares during the last quarter. LPL Financial LLC grew its stake in shares of Acadia Healthcare by 1.2% during the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock worth $1,651,000 after purchasing an additional 697 shares during the period. Finally, Quantinno Capital Management LP grew its stake in shares of Acadia Healthcare by 9.0% during the 4th quarter. Quantinno Capital Management LP now owns 8,695 shares of the company’s stock worth $345,000 after purchasing an additional 721 shares during the period.

Acadia Healthcare Stock Up 2.1%

Shares of NASDAQ:ACHC opened at $23.45 on Wednesday. The firm has a 50 day simple moving average of $22.10 and a 200-day simple moving average of $25.18. Acadia Healthcare has a twelve month low of $17.13 and a twelve month high of $79.82. The company has a market capitalization of $2.17 billion, a PE ratio of 15.53, a P/E/G ratio of 4.52 and a beta of 0.89. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same quarter in the prior year, the firm earned $0.91 EPS. Acadia Healthcare’s revenue for the quarter was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, equities analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.